Introduction The field of tumor-specific fluorescence-guided surgery has seen a significant increase in the development of novel tumor-targeted imaging agents. Studying patient benefit using intraoperative fluorescence-guided imaging for cancer surgery is the final step needed for implementation in standard treatment protocols. Translation into phase III clinical trials can be challenging and time consuming. Recent studies have helped to identify certain waypoints in this transition phase between studying imaging agent efficacy (phase I-II) and proving patient benefit (phase III). Trial initiation Performing these trials outside centers of expertise, thus involving motivated clinicians, training them, and providing feedback on data quality,...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...
The purpose of this study was to assess the potential of U.S. Food and Drug Administration-cleared d...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...
Introduction: The field of tumor-specific fluorescence-guided surgery has seen a significant increas...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Intraoperative visualization of tumors could be enhanced by the use of near-infrared (nir) fluoresce...
Fluorescence-guided surgery using tumour-targeted imaging agents has emerged over the past decade as...
During the European Molecular Imaging Meeting (EMIM) 2013, the fluorescence-guided surgery study gro...
BACKGROUND: In the past decade, there has been a major drive towards clinical translation of optical...
BackgroundIn the past decade, there has been a major drive towards clinical translation of optical a...
Optical image-guided cancer surgery is a promising technique to adequately determine tumor margins b...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...
The purpose of this study was to assess the potential of U.S. Food and Drug Administration-cleared d...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...
Introduction: The field of tumor-specific fluorescence-guided surgery has seen a significant increas...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Navigation with fluorescence guidance has emerged in the last decade as a promising strategy to impr...
Intraoperative visualization of tumors could be enhanced by the use of near-infrared (nir) fluoresce...
Fluorescence-guided surgery using tumour-targeted imaging agents has emerged over the past decade as...
During the European Molecular Imaging Meeting (EMIM) 2013, the fluorescence-guided surgery study gro...
BACKGROUND: In the past decade, there has been a major drive towards clinical translation of optical...
BackgroundIn the past decade, there has been a major drive towards clinical translation of optical a...
Optical image-guided cancer surgery is a promising technique to adequately determine tumor margins b...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...
The purpose of this study was to assess the potential of U.S. Food and Drug Administration-cleared d...
Fluorescence-guided surgery (FGS) and other interventions are rapidly evolving as a class of technol...